Cargando…
Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics
OBJECTIVE: Existing prognostic models for endometrial cancer are short of facility and effective validation. In this study, we aim to develop and validate a novel prognostic model for endometrial cancer based on clinical characteristics. METHODS: The clinical data such as age, BMI (body mass index),...
Autores principales: | Yu, Zhicheng, Wei, Sitian, Zhang, Jun, Shi, Rui, An, Lanfen, Feng, Dilu, Wang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637423/ https://www.ncbi.nlm.nih.gov/pubmed/34866940 http://dx.doi.org/10.2147/CMAR.S338861 |
Ejemplares similares
-
KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer
por: An, Lanfen, et al.
Publicado: (2021) -
N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021) -
Single‐cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer
por: Yu, Zhicheng, et al.
Publicado: (2022) -
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
por: Wei, Sitian, et al.
Publicado: (2022) -
CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer
por: Zhang, Jun, et al.
Publicado: (2022)